Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1995-12-4
|
pubmed:abstractText |
Vaginal progesterone suppositories are an accepted treatment for infertility attributed to luteal phase defects. Although oral micronized progesterone may be preferable to suppositories for many patients, there are no studies on its use for patients with luteal phase defects. This study evaluated the efficacy of oral micronized progesterone for the treatment of luteal phase defects.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0024-7758
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
521-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7473442-Administration, Oral,
pubmed-meshheading:7473442-Capsules,
pubmed-meshheading:7473442-Female,
pubmed-meshheading:7473442-Humans,
pubmed-meshheading:7473442-Luteal Phase,
pubmed-meshheading:7473442-Pessaries,
pubmed-meshheading:7473442-Progesterone,
pubmed-meshheading:7473442-Treatment Outcome
|
pubmed:year |
1995
|
pubmed:articleTitle |
Efficacy of oral micronized progesterone in the treatment of luteal phase defects.
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, University of Connecticut, Farmington, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|